Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
The aim of review. To analyze and present data of the foreign pharmacogenetic studies devoted to improvement of pharmacological therapy of colorectal cancer (CRC), in particular those, focused on the drugs with general cytostatic action: 5-fluorouracil derivatives, irinotecan and platinum agents.Sum...
Saved in:
Main Authors: | N. B. Zakharzhevskaya, N. A. Kulemin, Ye. A. Babikova, Ye. B. Khomyakova, E. V. Generozov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2015-12-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1040 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
by: O. I. Kit, et al.
Published: (2014-12-01) -
Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01) -
FROM ONCOLOGIST TO SURGEON - GENETICS IN COLORECTAL METASTASIS FOR SURGEONS
by: Marília Polo Mingueti e SILVA, et al.
Published: (2025-02-01) -
Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics
by: Simin Luo, et al.
Published: (2025-02-01) -
The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review
by: Faris Shweikeh, et al.
Published: (2024-01-01)